Lupin gains on getting USFDA’s approval for Fluoxetine Tablets

Date: 16-04-2019

Lupin is currently trading at Rs. 836.40, up by 6.20 points or 0.75% from its previous closing of Rs. 830.20 on the BSE.

The scrip opened at Rs. 831.05 and has touched a high and low of Rs. 843.95 and Rs. 827.10 respectively. So far 61199 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 986.00 on 10-Sep-2018 and a 52 week low of Rs. 720.40 on 28-Mar-2019.

Last one week high and low of the scrip stood at Rs. 843.95 and Rs. 799.40 respectively. The current market cap of the company is Rs. 37973.27 crore.

The promoters holding in the company stood at 46.98%, while Institutions and Non-Institutions held 38.84% and 14.18% respectively.

Lupin has received approval for its Fluoxetine Tablets USP, 10 mg and 20 mg, from the United States Food and Drug Administration (USFDA) to market a generic version of Eli Lilly and company’s (Eli Lilly) Prozac Tablets, 10 mg and 20 mg.

The company’s Fluoxetine Tablets USP, 10 mg and 20 mg, is the generic version of Eli Lilly’s Prozac Tablets, 10 mg and 20 mg. Fluoxetine Tablets, 10 mg and 20 mg, (RLD: Prozac) had annual sales of approximately $68.2 million in the US (IQVIA MAT December 2018).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Latest Financials

Latest Financials

 - Lupin Ltd.

  Standalone Consolidated
TTM EPS (Rs) 34 13.4
TTM Sales (Rs. Cr.) 11,032 16,369
BVPS (Rs.)
The total value that a company will fetch upon liquidation (if it is closed down), after settling all obligations is called its Book Value. Book value of a company includes only tangible assets. Book value allocated to each outstanding share is called Book Value per share
378.21 303.64
Reserves (Rs. Cr.)
The term reserve represents a part of shareholders' equity, except for basic share capital. Reserves are created from retained earnings and shareholders' contributions in the form of share premium etc.
17,027 13,652
P/BV
Price to Book Value is the ratio of stock's market value to its book value. It gives some idea of whether investors are paying too much for what would be left if the company went bankrupt immediately. To get high returns, it is advisable to invest in a company which satisfies all the criteria set by MoneyWorks4me and which has low price to book value ratio.
1.86 2.32
PE
It is the ratio of market price and earnings per share. It shows what the market is willing to pay for the company's earnings. To get high returns it is advisable to invest in the company which satisfies all the criteria set by MoneyWorks4me and which has low price to earnings ratio as compared to the industry.
20.69 52.49
From the Market
52 Week High / Low (Rs) 986.00/697.30
All Time High / Low (Rs) 2127.00/0.80
Volume Traded 60,448
Market Cap (Rs. Cr.) 31,837
Equity (Rs. Cr.) 90.52
Face Value (Rs) 2
Industry PE
Industry price to earnings per share tells on an average, what the market is willing to pay for overall earnings in that industry. It can be used as a benchmark price to earnings ratio for the companies in that industry.
27.95
703.45 0.00 (0.00%)
Jun 19, 18:59
Return to Top
Puchho Befikar